|
CETN3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.367900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.618000E-01 |
| Normal-vs-Stage2 |
9.671600E-01 |
| Normal-vs-Stage3 |
1.099630E-03 |
| Normal-vs-Stage4 |
9.178900E-03 |
| Stage1-vs-Stage2 |
5.297800E-01 |
| Stage1-vs-Stage3 |
3.483600E-03 |
| Stage1-vs-Stage4 |
3.265900E-02 |
| Stage2-vs-Stage3 |
3.648300E-02 |
| Stage2-vs-Stage4 |
7.417800E-02 |
| Stage3-vs-Stage4 |
6.709400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.233380E-01 |
| Normal-vs-AfricanAmerican |
3.785600E-02 |
| Normal-vs-Asian |
2.167200E-01 |
| Caucasian-vs-AfricanAmerican |
3.585600E-01 |
| Caucasian-vs-Asian |
5.764600E-01 |
| AfricanAmerican-vs-Asian |
8.194200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.767800E-02 |
| Normal-vs-Female |
1.755190E-01 |
| Male-vs-Female |
6.129400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.556300E-02 |
| Normal-vs-Age(41-60Yrs) |
7.372200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.583570E-01 |
| Normal-vs-Age(81-100Yrs) |
2.184500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.871400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.075800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.637000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.434200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.996200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.091800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.668400E-01 |
| Normal-vs-Grade 2 |
8.521400E-01 |
| Normal-vs-Grade 3 |
7.862200E-03 |
| Normal-vs-Grade 4 |
4.04880000000052E-05 |
| Grade 1-vs-Grade 2 |
2.899000E-01 |
| Grade 1-vs-Grade 3 |
3.749800E-01 |
| Grade 1-vs-Grade 4 |
5.991500E-02 |
| Grade 2-vs-Grade 3 |
4.259200E-03 |
| Grade 2-vs-Grade 4 |
2.35490000000116E-06 |
| Grade 3-vs-Grade 4 |
1.422260E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.947600E-01 |
| Normal-vs-ccB subtype |
1.151320E-04 |
| ccA subtype-vs-ccB subtype |
4.81619999992411E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.969600E-02 |
| Normal-vs-N1 |
7.960400E-02 |
| N0-vs-N1 |
3.761400E-01 |
|
|
